# Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/neoadjuvant-cemiplimab-for-resectable-hepatocellular-carcinoma-a-single-arm-open/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Thomas U. Marron,Maria Isabel Fiel,Pauline Hamon,Nathalie Fiaschi,Edward Kim,Stephen C. Ward,Zhen Zhao,Joel Kim,Paul Kennedy,Ganesh Gunasekaran,Parissa Tabrizian,Deborah B. Doroshow,Meredith Legg,Ashley Hammad,Assaf Magen,Alice O. Kamphorst,Muhammed Shareef,Namita Gupta,Raquel P. Deering,Wei Wang,Fang Wang,Pradeep Thanigaimani,Jayakumar Mani,Leanna Troncoso,Alexandra Tabachnikova,Christie Chang,Güray Aktürk,Mark Buckup,Steven Hamel,Giorgio Ioannou,C. Hennequin,Hajra Jamal,Haley E. Brown,Antoinette Bonaccorso,Daniel M. Labow,Umut Sarpel,Talia D. Rosenbloom,Max W. Sung,Baijun Kou,Siyu Li,Vladimir Janković,Nicola James,Sara Hamon,Hung Kam Cheung,Jennifer S. Sims,Elizabeth Miller,Nina Bhardwaj,Gavin Thurston,Israel Lowy,Sacha Gnjatic,Bachir Taouli,Myron Schwartz,Miriam Mérad |
| Citations | 228 |
| DOI | 10.1016/s2468-1253(21)00385-x |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/9901534 |
| OpenAlex ID | https://openalex.org/W4206656883 |
| PMID | 35065058 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Wei Wang](https://scholariq.org/researchers/wei-wang-4/)

## Paper journal

- [˜The œLancet. Gastroenterology & hepatology](https://scholariq.org/journals/the-lancet-gastroenterology-and-hepatology/)

## Paper primary topic

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)

## Paper topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.